Diagnostic Yield of Next-Generation Sequencing in Very Early-Onset Inflammatory Bowel Diseases: A Multicenter Study - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Crohn's and Colitis Année : 2018

Diagnostic Yield of Next-Generation Sequencing in Very Early-Onset Inflammatory Bowel Diseases: A Multicenter Study

Fabienne Charbit-Henrion (1, 2, 3) , Marianna Parlato (1, 3) , Sylvain Hanein (4) , Rémi Duclaux-Loras (3, 1) , Jan Nowak (3, 1, 5) , Bernadette Begue (3, 1) , Sabine Rakotobe (3, 1) , Julie Bruneau (2, 1) , Cécile Fourrage (6, 1) , Olivier Alibeu (4, 1) , Frédéric Rieux-Laucat (1, 7) , Eva Lévy (1, 7) , Marie-Claude Stolzenberg (7, 1) , Fabienne Mazerolles (7, 1) , Sylvain Latour (8, 1) , Christelle Lenoir (1, 8) , Alain Fischer (2, 9, 1, 4) , Capucine Picard (10, 2, 8) , Marina Aloi (11) , Jorge Amil Dias (12) , Mongi Ben Hariz (13) , Anne Bourrier (14) , Christian Breuer (15) , Anne Breton (16) , Stephan Buderus (17) , Mara Cananzi (18) , Stéphanie Coopman (19) , Clara Crémilleux (20) , Alain Dabadie (21) , Clémentine Dumant-Forest (22) , Odul Egritas Gurkan (23) , Alexandre Fabre (24) , Aude Fischer (25) , Marta German Diaz (26) , Yago Gonzalez-Lama (27) , Olivier Goulet (10, 2) , Olivier Goulet (10, 2) , Graziella Guariso (28) , Neslihan Gurcan (23) , Matjaz Homan (29) , Jean-Pierre Hugot (30, 31) , Eric Jeziorski (32, 33) , Evi Karanika (34) , Alain Lachaux (35, 36) , Peter Lewindon (37) , Rosa Lima (12) , Fernando Magro (38, 12) , Janos Major (39) , Georgia Malamut (40, 3) , Emmanuel Mas (41, 42) , Istvan Mattyus (43) , Luisa M. Mearin (44) , Jan Melek (45) , Victor Manuel Navas-Lopez (46) , Anders Paerregaard (47) , Cecile Pelatan (48) , Bénédicte Pigneur (2, 3) , Isabel Pinto Pais , Julie Rebeuh (49) , Claudio Romano (50) , Nadia Siala (13) , Caterina Strisciuglio (51) , Michela Tempia-Caliera , Patrick Tounian (52) , Dan Turner , Vaidotas Urbonas (53) , Stéphanie Willot (54) , Frank Ruemmele (2, 3) , Nadine N. Cerf-Bensussan (3)
1 Université Paris Descartes, Sorbonne Paris Cité
2 Hôpital Necker - Enfants Malades [AP-HP]
3 Equipe Inserm U1163 - Laboratory of Intestinal Immunity
4 IMAGINE - U1163 - Imagine - Institut des maladies génétiques
5 PUMS - Poznan University of Medical Sciences [Poland]
6 Equipe Inserm U1163 - The Clinical Bioinformatics laboratory
7 Equipe Inserm U1163 - Immunogenetics of pediatric autoimmune diseases
8 Equpie Inserm U1163 - Lymphocyte activation and susceptibility to EBV
9 CdF (institution) - Collège de France
10 UPD5 - Université Paris Descartes - Paris 5
11 UNIROMA - Università degli Studi di Roma "La Sapienza" = Sapienza University [Rome]
12 Hospital de São João [Porto]
13 Centre Hospitalier Universitaire Mongi Slim [La Marsa]
14 CHU Saint-Antoine [AP-HP]
15 UKE - Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg]
16 CHU Toulouse - Centre Hospitalier Universitaire de Toulouse
17 University Hospital Motol [Prague]
18 University Hospital Bonn
19 CHRU Lille - Centre Hospitalier Régional Universitaire [CHU Lille]
20 CHU ST-E - Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne]
21 Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Ponchaillou]
22 Service de pédiatrie médicale et médecine de l'adolescent [Rouen]
23 Gazi University
24 APHM - Assistance Publique - Hôpitaux de Marseille
25 CHU Saint-Pierre
26 Hospital Universitario 12 de Octubre [Madrid]
27 Hospital Universitario Puerta de Hierro-Majadahonda [Madrid, Spain]
28 Unipd - Università degli Studi di Padova = University of Padua
29 UMCL - University Medical Centre Ljubljana [Ljubljana, Slovenia]
30 Inflammation intestinale pathologique de l'enfant
31 AP-HP Hôpital universitaire Robert-Debré [Paris]
32 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]
33 PCCEI - Pathogenesis and Control of Chronic and Emerging Infections
34 General Hospital of Thessaloniki "Ippokrateio"
35 CarMeN - Cardiovasculaire, métabolisme, diabétologie et nutrition
36 HFME - Hôpital Femme Mère Enfant [CHU - HCL]
37 UQ [All campuses : Brisbane, Dutton Park Gatton, Herston, St Lucia and other locations] - The University of Queensland
38 Universidade do Porto = University of Porto
39 Pál Heim Children's Hospital = Heim Pál Gyermekkórház [Budapest]
40 HEGP - Hôpital Européen Georges Pompidou [APHP]
41 Service de Gastroentérologie et pancréatologie [CHU Toulouse]
42 Service Gastroentérologie, hépatologie nutrition, diabétologie et maladies héréditaires du métabolisme pédiatrique [CHU Toulouse]
43 Semmelweis University [Budapest]
44 Universiteit Leiden = Leiden University
45 University of Hradec Králové
46 Hospital Regional Universitario de Málaga = Regional University Hospital of Malaga [Spain]
47 Copenhagen University Hospital
48 Centre Hospitalier Le Mans (CH Le Mans)
49 CHU Strasbourg - Centre Hospitalier Universitaire [Strasbourg]
50 University of Messina
51 Seconda Università degli Studi di Napoli = Second University of Naples
52 CHU Trousseau [APHP]
53 Vilnius University [Vilnius]
54 CHU Trousseau [Tours]
Sylvain Hanein
  • Fonction : Auteur
  • PersonId : 890853
Anne Breton
  • Fonction : Auteur
  • PersonId : 907891
Alexandre Fabre
  • Fonction : Auteur
  • PersonId : 1076689
Aude Fischer
  • Fonction : Auteur
Neslihan Gurcan
  • Fonction : Auteur
Isabel Pinto Pais
  • Fonction : Auteur
Michela Tempia-Caliera
  • Fonction : Auteur
Patrick Tounian
Dan Turner
  • Fonction : Auteur

Résumé

Background and Aims: An expanding number of monogenic defects have been identified as causative of severe forms of very early-onset inflammatory bowel diseases (VEO-IBD). The present study aimed at defining how next-generation sequencing (NGS) methods can be used to improve identification of known molecular diagnosis and adapt treatment. Methods: 207 children were recruited in 45 Paediatric centres through an international collaborative network (ESPGHAN GENIUS working group) with a clinical presentation of severe VEO-IBD (n=185) or an anamnesis suggestive of a monogenic disorder (n=22). Patients were divided at inclusion into three phenotypic subsets: predominantly small bowel inflammation, colitis with perianal lesions, and colitis only. Methods to obtain molecular diagnosis included functional tests followed by specific Sanger sequencing, custom-made targeted NGS, and in selected cases whole exome sequencing (WES) of parents-child trios. Genetic findings were validated clinically and/or functionally. Results: Molecular diagnosis was achieved in 66/207 children (32%): 61% with small bowel inflammation, 39% with colitis and perianal lesions and 18% with colitis only. Targeted NGS pinpointed gene mutations causative of atypical presentations and identified large exonic copy number variations previously missed by WES. Conclusions: Our results lead us to propose an optimised diagnostic strategy to identify known monogenic causes of severe IBD.
Fichier principal
Vignette du fichier
jjy068.pdf (4.1 Mo) Télécharger le fichier
jjaa164.pdf (157.4 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Licence : CC BY NC - Paternité - Pas d'utilisation commerciale
Licence : CC BY - Paternité

Dates et versions

hal-02320500 , version 1 (19-02-2024)
hal-02320500 , version 2 (22-02-2024)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Fabienne Charbit-Henrion, Marianna Parlato, Sylvain Hanein, Rémi Duclaux-Loras, Jan Nowak, et al.. Diagnostic Yield of Next-Generation Sequencing in Very Early-Onset Inflammatory Bowel Diseases: A Multicenter Study. Journal of Crohn's and Colitis, 2018, 12 (9), pp.1104-1112. ⟨10.1093/ecco-jcc/jjy068⟩. ⟨hal-02320500v1⟩
215 Consultations
6 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More